{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:46:16Z","timestamp":1772491576912,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.taap.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T17:30:11Z","timestamp":1501695011000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Species-specific effects of neuregulin-1\u03b2 (cimaglermin alfa) on glucose handling in animal models and humans with heart failure"],"prefix":"10.1016","volume":"332","author":[{"given":"Zhihong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika L.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corissa","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Cleator","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony O.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0300-9084(91)90076-D","article-title":"Glucose transporters: structure, function and regulation","volume":"73","author":"Assimacopoulos-Jeannet","year":"1991","journal-title":"Biochemie"},{"key":"10.1016\/j.taap.2017.08.001_bb0010","first-page":"E54","article-title":"Growth hormone response to GRF and insulin-induced hypoglycemia in Yorkshire and Meishan pigs","volume":"264","author":"Bonneau","year":"1993","journal-title":"Am. J. Phys."},{"issue":"4","key":"10.1016\/j.taap.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jsm.12834","article-title":"GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction","volume":"12","author":"Burnett","year":"2015","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.taap.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.diabet.2015.08.003","article-title":"Neuregulin 1 improves glucose tolerance in adult and old rats","volume":"42","author":"Caillaud","year":"2016","journal-title":"Diabete Metab."},{"key":"10.1016\/j.taap.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1074\/jbc.M308554200","article-title":"Neuregulin signaling on glucose transport in muscle cells","volume":"279","author":"Cant\u00f3","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.taap.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2337\/db06-1726","article-title":"Neuregulins increase mitochondrial oxidative capacity and insulin sensitivity in skeletal muscle cells","volume":"56","author":"Cant\u00f3","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.taap.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1471-4159.2011.07284.x","article-title":"Systemic administration of Neuregulin-1\u03b21 protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"117","author":"Carlsson","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2017.08.001_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0092-8674(94)90564-9","article-title":"A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling","volume":"78","author":"Carraway","year":"1994","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.taap.2017.08.001_bb0045","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1210\/endo.138.12.5601","article-title":"Hepatic expression of ErbB3 is repressed by insulin in a pathway sensitive to PI-3 kinase inhibitors","volume":"138","author":"Carver","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14573\/1309231","article-title":"Of rodents and men: species-specific glucose regulation and type 2 diabetes research","volume":"31","author":"Chandrasekera","year":"2014","journal-title":"ALTEX"},{"issue":"2","key":"10.1016\/j.taap.2017.08.001_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cbpa.2006.10.029","article-title":"Distribution patterns of the glucose transporters GLUT4 and GLUT1 in skeletal muscles of rats (Rattus norvegicus), pigs (Sus scrofa), cows (Bos taurus), adult goats, goat kids (Capra hircus), and camels (Camelus dromedarius)","volume":"146","author":"Duehlmeier","year":"2007","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"issue":"7","key":"10.1016\/j.taap.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"e0130568","DOI":"10.1371\/journal.pone.0130568","article-title":"Neuregulin 1 improves glucose tolerance in db\/db mice","volume":"10","author":"Ennequin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.08.001_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","article-title":"Neuregulins: function, forms, and signaling strategies","volume":"284","author":"Falls","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.taap.2017.08.001_bb0070","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.taap.2017.08.001_bb0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.yjmcc.2003.09.012","article-title":"Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase\/Akt","volume":"35","author":"Fukazawa","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.taap.2017.08.001_bb0080","doi-asserted-by":"crossref","first-page":"e000773","DOI":"10.1161\/JAHA.113.000773","article-title":"Anti-remodeling and anti-fibrotic effects of the neuregulin-1\u03b2 glial growth factor 2 in a large animal model of heart failure","volume":"3","author":"Galindo","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.taap.2017.08.001_bb0085","doi-asserted-by":"crossref","first-page":"E742","DOI":"10.1152\/ajpendo.00541.2009","article-title":"Emerging role of neuregulin as a modulator of muscle metabolism","volume":"298","author":"Gum\u00e0","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2017.08.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb29b03s77","article-title":"Evaluation of glucose homeostasis","author":"Heikkinen","year":"2007","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.taap.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"e55741","DOI":"10.1371\/journal.pone.0055741","article-title":"Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1beta improves left ventricular function, gene and protein expression in rats after myocardial infarction","volume":"8","author":"Hill","year":"2013","journal-title":"PLoS One"},{"issue":"7\u20138","key":"10.1016\/j.taap.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuropharm.2010.07.017","article-title":"Glial growth factor 2 promotes functional recovery with treatment initiated up to 7days after permanent focal ischemic stroke","volume":"59","author":"Iaci","year":"2010","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.taap.2017.08.001_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jnr.23699","article-title":"An optimized dosing regimen of cimaglermin (neuregulin 1\u03b23, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats","volume":"94","author":"Iaci","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/333183a0","article-title":"Insulin-regulatable tissue express a unique insulin-sensitive glucose transport protein","volume":"333","author":"James","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.taap.2017.08.001_bb0115","doi-asserted-by":"crossref","first-page":"19469","DOI":"10.1074\/jbc.M600399200","article-title":"Role of neuregulin-1\/ErbB2 signaling in endothelium-cardiomyocyte cross-talk","volume":"281","author":"Lemmens","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.taap.2017.08.001_bb0120","first-page":"576","article-title":"A phase I, single ascending dose study of cimaglermin alfa (neuregulin 1\u03b23) in patients with systolic dysfunction and heart failure","volume":"1","author":"Lenihan","year":"2016","journal-title":"Am. Coll. Cardiol. Basic Trans. Sci."},{"issue":"1","key":"10.1016\/j.taap.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4238\/2015.February.13.7","article-title":"Developmental changes in the expression of the GLUT2 and GLUT4 genes in the longissimus dorsi muscle of Yorkshire and Tibetan pigs","volume":"14","author":"Liang","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"7","key":"10.1016\/j.taap.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2006.05.057","article-title":"Neuregulin-1\/erbB \u2013 activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy","volume":"48","author":"Liu","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.taap.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"E440","DOI":"10.1152\/ajpendo.00226.2015","article-title":"Neuregulin improves response to glucose tolerance test in control and diabetic rats","volume":"310","author":"L\u00f3pez-Soldado","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.1152\/ajpendo.00002.2006","article-title":"Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant, type 2 diabetic patients","volume":"291","author":"Lucotti","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2016.12.024","article-title":"Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction","volume":"796","author":"Parry","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.taap.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diacare.24.5.875","article-title":"Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients","volume":"24","author":"Piatti","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0090-9556(24)15122-7","article-title":"Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs and pigs and pharmacodynamics of insulin aspart in pigs","volume":"28","author":"Plum","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2017.08.001_bb0160","first-page":"H2205","article-title":"Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis","volume":"277","author":"Russell","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.taap.2017.08.001_bb0165","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.CIR.0000013839.41224.1C","article-title":"Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity","volume":"105","author":"Sawyer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2017.08.001_bb0170","doi-asserted-by":"crossref","first-page":"18257","DOI":"10.1074\/jbc.M008100200","article-title":"A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells","volume":"276","author":"Su\u00e1rez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.08.001_bb0175","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"USFDA","year":"2005"},{"issue":"2","key":"10.1016\/j.taap.2017.08.001_bb0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/glia.21262","article-title":"GGF2 (Nrg1-\u03b23) treatment enhances NG2+ cell response and improves functional recovery after spinal cord injury","volume":"60","author":"Whittaker","year":"2012","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.taap.2017.08.001_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.taap.2017.08.001_bb0190","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02817.x","article-title":"Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures","volume":"91","author":"Zhang","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2017.08.001_bb0195","doi-asserted-by":"crossref","first-page":"10261","DOI":"10.1074\/jbc.273.17.10261","article-title":"Neuregulins promote survival and growth of cardiac myocytes: persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes","volume":"273","author":"Zhao","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:09:30Z","timestamp":1750795770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17303265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0041008X17303265"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.08.001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Species-specific effects of neuregulin-1\u03b2 (cimaglermin alfa) on glucose handling in animal models and humans with heart failure","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}